 PRINCETON, N.J., Dec. 22, 2020 PRNewswire -- Soligenix, Inc. NASDAQ: SNGX Soligenix or the Company, a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today preliminary... 